Answers are grounded in this paper and cite their sources.
Our findings indicate that there is substantial variation in G6PD measurements by spectrophotometry between sites. This is likely due to variability in laboratory methods, with possible contribution of unmeasured population factors. While an assay-specific, universal quantitative threshold offers robust diagnosis at the 30% level, inter-study variability impedes performance of universal thresholds at the 70% level. Caution is advised in comparing findings based on absolute G6PD activity measurements across studies. Novel handheld quantitative G6PD diagnostics may allow greater standardisation in the future.
No takes yet. Share an insight, caveat, or question.
Pfeffer et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: